Brief: Pharmasimple H1 EBITDA loss stable at 0.4 million euros
Sept 18 (Reuters) - PHARMASIMPLE SA ALPHS.PA :
* H1 REVENUE EUR 9.5 MILLION VERSUS EUR 5.7 MILLION YEAR
AGO
* H1 EBITDA LOSS EUR 0.4 MILLION VERSUS LOSS OF EUR 0.4
MILLION YEAR AGO
* H1 NET LOSS EUR 0.6 MILLION VERSUS LOSS EUR 0.5 MILLION
YEAR AGO
* OUTLOOK FOR 2017: ACCELERATION IN ACTIVITY GROWTH IN H2
AND EXPECTED IMPROVEMENT IN PROFITABILITY
Source text: http://bit.ly/2xtkPMA
Further company coverage: ALPHS.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months